Top Industry Leaders in the Achondrogenesis Market
Latest Achondrogenesis Companies Updates:
BioMarin Pharmaceutical Inc Develops Vosoritide, a medication approved for the treatment of Achondroplasia and currently being investigated for its potential in Achondrogenesis.
Horizon Therapeutics plc Develops pegvisomant, a growth hormone receptor antagonist used in various growth disorders, including Achondrogenesis.
Acceleron Pharma Collaborates with BioMarin on the development of Vosoritide.
List of Achondrogenesis Key companies in the market:
- Cook
- Thermo Fisher Scientific
- CooperSurgical Inc.
- Illumina, Inc.
- Siemens AG
- FUJIFILM Holdings Corporation
- Koninklijke
- Philips N.V
- Stryker,
- Toshiba Corporation
- Invivoscribe
- Abbott Molecular Inc.
- INVITROGEN CORPORATION
- Roche Molecular Systems, Inc.